Movement Alert|Vertiv Holdings LLC Rises 4.22% in Pre-Market Trading, Multiple Investment Banks Affirm Q3 Recovery Outlook

Market Focus
Jul 31

On July 31, Vertiv Holdings LLC rose 4.22% in pre-market trading, trading at $237.55/share, with turnover of $2.2887 million. The stock continues its recovery from a 17%+ selloff earlier in the week after Q2 revenue missed expectations.

On the news front, UBS and Oppenheimer simultaneously published research reports offering positive assessments of the company's outlook. UBS noted that management attributed the Q2 revenue shortfall to \"timing shifts\" caused by supply chain congestion, implying that growth is expected to meaningfully recover in Q3. The brokerage reiterated its buy rating and $370 price target. Oppenheimer highlighted strengthening demand, a broadening pipeline across geographies and product categories, and accelerating July shipments that track in line with the company's guided second-half revenue outlook.

For context, Vertiv reported Q2 adjusted EPS of $1.52, beating the $1.42 consensus by 7% and growing 60% year-over-year, while revenue of $3.27 billion fell $110 million short of expectations. The company raised its full-year revenue guidance midpoint to $14 billion and adjusted EPS guidance to $6.65-$6.75, both above prior Street estimates.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10